Literature frequently reports that colloids in aqueous matrices sorb a large fraction of pharmaceuticals. Since coagulation/flocculation removes colloids, it is expected that coagulation/flocculation in principle should be useful in concentrating pharmaceuticals in wastewater treatment, which would facilitate the treatment of these refractory compounds. In our present work, we researched the potential of coagulation/flocculation for removing pharmaceuticals from raw sewage. Results from jar tests showed that pharmaceuticals are hardly removed from sewage with coagulation/flocculation. To investigate the discrepancy between reported colloidal sorption and the lack of removal when removing colloids, we tested a commonly applied experimental setup, which makes use of ultra-filtration (UF), for determining the colloidal sorption of pharmaceuticals. The UF method under research was compared with an assessment making use of flocculation. Both methods, UF and flocculation, showed similar removal of colloids. However, during UF, the retention of pharmaceuticals reached values up to 93 ± 4 %. In contrast, when removing the colloids with flocculation, no pharmaceutical removal was observed. These results confirm that it is very likely to introduce an analysis bias in using UF membranes in the determination of colloidal sorption of pharmaceuticals. In fact, results predict an over-estimation caused by a direct retention of pharmaceuticals without any binding to colloidal matter. Overall results of the current work show that pharmaceuticals hardly sorb to colloids and herewith the absence of removal of pharmaceuticals during coagulation/flocculation is explained.@en

In this work, we investigated the effects of flocculation aid (FA) addition to an anaerobic dynamic membrane bioreactor (AnDMBR) (7 L, 35°C) treating waste-activated sludge (WAS). The experiment consisted of three distinct periods. In period 1 (day 1–86), the reactor was operated as a conventional anaerobic digester with a solids retention time (SRT) and hydraulic retention time (HRT) of 24 days. In period 2 (day 86–303), the HRT was lowered to 18 days with the application of a dynamic membrane while the SRT was kept the same. In period 3 (day 303–386), a cationic FA in combination with FeCl3 was added. The additions led to a lower viscosity, which was expected to lead to an increased digestion performance. However, the FAs caused irreversible binding of the substrate, lowering the volatile solids destruction from 32% in period 2 to 24% in period 3. An accumulation of small particulates was observed in the sludge, lowering the average particle size by 50%. These particulates likely caused pore blocking in the cake layer, doubling the trans-membrane pressure. The methanogenic consortia were unaffected. Dosing coagulants and flocculants into an AnDMBR treating sludge leads to a decreased cake layer permeability and decreased sludge degradation.@en

To lower energy consumption at a sewage treatment plant (STP), primary settling could be enhanced to direct more chemical oxygen demand (COD) to anaerobic digestion (AD) for increased biogas production and decreased aeration. Primary settling can be chemically enhanced by applying flocculation aids (FAs). FAs are refractory compounds that may affect all sludge treatment facilities. In this study the consequences are investigated of the application of FAs for chemically enhanced primary treatment (CEPT) on AD and subsequent dewatering of digested sludge in a conventional STP. It was found that FAs maintain their effect throughout all sludge processing facilities. With CEPT, more readily degradable solids were removed, resulting in a higher bio methane potential of the primary sludge. In AD, FAs lowered the viscosity; meanwhile an increased hydrolysis rate was observed. But FAs also partially irreversibly bound substrate in such way that it is not available for biological degradation anymore. In subsequent dewatering of digested sludge, a higher dry solids concentration was observed with CEPT. A computer simulation showed that in a conventional STP, CEPT would not be economically feasible. However, several benefits were discussed that can make CEPT an interesting option for future low COD/N-tolerant STPs with, for example, Anammox processes for N removal.@en